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Background: Since the reference value is the core factor of the T-score calculation, it has a significant impact on
the prevalence of osteoporosis. The purpose of this study was to determine the effects of using the Korean reference
value on the prevalence of osteoporosis and on the prediction of fracture risk.
Methods: We used femoral neck bone mineral density (BMD) data from the Korea National Health and Nutrition
Examination Survey (KNHANES) 2008–2011. The Korean reference was identified by the mean and standard deviation
of men and women aged 20–29 years. We compared the prevalence and the fracture risk assessment tool (FRAX™)
probability obtained from the Korean reference and the NHANES III reference.
Results: In men, the prevalence of osteoporosis increased when using the Korean men’s reference, and the difference
increased up to 9% for those in their 80s. In women, the prevalence increased when using the NHANES III reference,
and the difference increased up to 17% for those in their 80s. The reference value also affected the fracture risk
probability, and the difference from changing the reference value increased in women and in subjects with more
clinical fracture risk factors. In major osteoporotic fractures, the difference of the risk probability was up to 6% in
women aged 70–79 years with two clinical risk factors. For femoral neck fractures, the difference was up to 7% in
women aged 50–59 years with two clinical risk factors.
Conclusions: We confirmed that the reference value had significant effects on the prevalence of osteoporosis and on
the fracture risk probability. The KNHANES 2008–2011 BMD data reflected the characteristics of the Korean BMD status
well with regard to data size and study design; therefore, these data can be used as reference values.
Keywords: Bone mineral density, Fracture risk, FRAX, Korean reference value, Osteopenia, Osteoporosis, Prediction of
fracture risk, Prevalence, Reference, T-scoreBackground
The diagnostic criteria for osteoporosis are based on the
T-score, which is calculated from the mean bone mineral
density (BMD), and its standard deviation of the refer-
ence from the young adult group in the World Health
Organization’s (WHO) consensus of 1993 [1]. Because
the T-score depends on the value of a reference group,
the definition of the reference group has been controver-
sial [2-8]. While one group suggested using the universal* Correspondence: jaemyungyu@hotmail.com
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women from the National Health and Nutrition Examin-
ation Survey (NHANES) III, another group suggested
using the regional reference BMD data of a region- and
race-specific young adult group. Meanwhile, the main
guidelines suggest the former, and this is based on sev-
eral reasons [9-12]. First, the prevalence of each group
of osteoporosis is significantly different, but it is small
when compared with the difference in fracture incidence
by region. Therefore, the benefit of using local reference
BMD data in terms of predicting fracture is not clear
[12,13]. Second, it is realistic to use the NHANES IIIis is an Open Access article distributed under the terms of the Creative
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in areas where there is no equivalent BMD data.
The aforementioned reasons may be valid for using a
universal reference in an area where osteoporosis treat-
ment is based on the assessment of fracture risk. If we
use the fracture risk assessment tool (FRAX™), the BMD
value itself is used rather than the T-score. Therefore,
the decision for medical treatment will receive less influ-
ence from the T-score and the reference value. However,
in many regions, the use of medical prediction tools
such as the FRAX™ is limited, and osteoporosis diagnosis
and treatment is based on the T-score [14]. Thus, in
such areas, the T-score and related reference BMD data
still have great influence on the diagnosis and treatment
of osteoporosis and the standard for reimbursement.
Additionally, the drug holiday, which is based on the risk
assessment according to the T-score after 3–5 years
of bisphosphonate therapy, is suggested [15-19]. The
reference BMD value also has a significant impact in this
case.
The first aim of this study was to estimate the effect
of changing the reference value (obtained from the
Korean BMD data and white women BMD data from
the NHANES III) on the prevalence of osteoporosis by
sex and age group. The second aim was to evaluate the
effects of the change of reference value on the fracture
risk probability by comparing the FRAX™ 10-year risk
probability obtained from each T-score. In Korea, there
is no clear definition for the reference group; thus, our
study may be used as important material for determining




We used the BMD data from the Korea National
Health and Nutrition Examination Survey (KNHANES;
2008–2011). This survey is administered nationwide
and has been conducted since 1995 in South Korea by
the Korea Centers for Disease Control and Prevention.
The KNHANES from 2008–2009 was administered to
4,600 households from 200 primary sampling units, while
the KNHANES from 2010–2011 was administered to
3,800 households from 192 primary sampling units each
year. First, the primary units were selected by the adminis-
trative regions; one study unit was extracted from each
area after considering the type of house. Second, 20
households from each study unit were extracted using a
systematic sampling method, and these households were
the basic units in the survey. By using the rolling survey
sampling, a sample from each year was representative of
the population of that respective year.
The KNHANES was composed of a health interview
survey, nutritional survey, and a health examinationsurvey. The health interview and health examination
surveys were administered in a mobile examination
center, and the nutritional survey was administered by
direct visit and interview. The health interview survey
was administered via a direct interview when the sub-
jects visited the mobile center; however, alcohol use and
current smoking status were surveyed by using a self-
reporting questionnaire. The health examination survey
was analyzed by using measurements, observation, and
laboratory sampling.
The subjects were men and women who received the
test for BMD during the KNHANES from 2008–2011
[20,21]. There was no significant difference between sub-
jects who did not receive a BMD scan and those who did;
thus, the risk of selection bias was very low. The subjects
used for investigating the Korean reference value were
20–29-year-old males and females. The analysis comparing
the prevalence and fracture risk probability was conducted
to target men and postmenopausal women >50 years.
Menopause was determined by the subjects’ responses
to the following survey items: (1) those who answered
natural menopause or menopause-related procedure to
the question, why do you not menstruate?; (2) when the
subjects’ period since the last menstruation was >1 year;
and (3) those who answered yes or bilateral ovariectomy
to menopause status. Women who satisfied all three
conditions were considered postmenopausal. Postmeno-
pausal women from 50–64 years and women >65 years
were included in the analysis of the prevalence of osteo-
porosis and fracture risk probability. The BMD data
from the NHANES III were used to compare the BMD
of white women from the United States NHANES III to
the value of men and women from the KNHANES [22].
The content and methodology of the KNHANES was
approved by the institutional review board of the Korea
Centers for Disease Control and Prevention, and all the
participants signed informed consent.
Measurement of bone mineral density, the reference
value, and diagnosis for osteoporosis
The BMD test was performed by a trained radiographer
in a mobile examination center using dual-energy radiog-
raphy absorptiometry (DXA; DISCOVERY-W fan-beam
densitometer; Hologic, Bedford, MA, USA) of the lumbar
spine (L1–L4) and proximal hip (femoral neck and total
femur). Hologic Discovery software, version 3.1 was used
for that device. The accuracy was investigated by perform-
ing double scans on 30 randomly selected subjects, and
the accuracy was maintained within the range of 0.73–
1.07% for the lumbar spine, 1.20–2.14% for the femoral
neck, and 0.71–1.18% for the total hip. Daily calibration
was performed by a phantom served by the company.
In this study, we analyzed the BMD of the femoral
neck. The reference value for Koreans was set to the
Table 1 Baseline characteristics of the subjects
Male Age n BMD (g/cm2) Height (cm) Weight (kg)
50–59 1,448 0.7879 ± 0.1118 168.36 ± 5.70 68.64 ± 9.26
60–69 1,410 0.7453 ± 0.1125 166.23 ± 5.66 65.78 ± 9.25
70–79 958 0.6864 ± 0.1103 164.56 ± 5.65 62.08 ± 9.52
80–89 182 0.6329 ± 0.1176 162.36 ± 5.60 58.38 ± 8.90
Female Age n BMD (g/cm2) Height (cm) Weight (kg)
50–59 1,395 0.6832 ± 0.0960 155.47 ± 5.21 58.39 ± 8.02
60–69 1,697 0.6156 ± 0.0870 153.40 ± 5.21 57.71 ± 8.17
70–79 1,282 0.5486 ± 0.0876 150.04 ± 5.55 54.36 ± 8.92
80–89 304 0.4875 ± 0.0831 147.10 ± 5.49 49.63 ± 8.72
BMD, bone mineral density.
Table 2 The reference values (gm/cm2) for femoral neck
fractures
Mean SD Cut-off BMD*
(gm/cm2)
KNHANES 2008–2011 Male 0.9123 0.1336 0.5783
NHANES III Female 0.8525 0.1189 0.5553
KNHANES 2008–2011 Female 0.7740 0.1045 0.5128
SD, standard deviation; BMD, bone mineral density; KNHANES, Korea National
Health and Nutrition Examination Survey.
*Cut-off BMD: BMD corresponding to a T-score of −2.5.
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aged 20–29 years. We used the mean BMD and standard
deviation (SD) (0.858 ± 0.120 g/cm2) published in a previ-
ous study as the NHANES III reference [23]. Osteoporosis,
osteopenia, and normal were defined using the following
T-scores according to the WHO criteria: ≤ − 2.5, −1.0
to −2.5, and −1.0, respectively.
Estimation of the fracture probability that corresponds to
each reference
The 10-year fracture risk was calculated by the Korea
FRAX™ version to assess how the change in the refer-
ence affects the relationship between BMD and fracture
risk prediction [24]. The BMD that corresponds to each
T-score −1.5, −2, −2.5, −3.0, −3.5, and −4.0) will vary de-
pending on the reference value. For example, a T-score
of −2.5 corresponded to 0.5128 g/cm2 when using a
Korean women reference and to 0.5553 g/cm2 when using
a NHANES III reference. When these different BMDs
were used in FRAX™, the fracture risk probability was cal-
culated as 6% and 6.8%, respectively. For weight and
height, the mean values of each age and sex group were
used. The difference of fracture risk probability by the
references was analyzed by age group and by the number
of clinical risk factors for fracture. To simplify the analysis,
only a history of fracture and a family history of hip frac-
ture in a parent of two estimates were analyzed.
Statistical analysis
Statistical analyses were performed using SPSS for
Windows, version 21.0 (SPSS Inc., Chicago, IL, USA).
Continuous variables were described in the form of
mean ± SD; the prevalence was presented as a percent-
age (%). Firstly, the subjects were partitioned into 10-
year age groups, and the mean and SD of BMD of each
age group was calculated. The mean BMDs did not
satisfy the assumption of equal variance, so the Welch’s
test and Tamhane’s T2 post-hoc analysis were used
to test the significance of the difference between the
mean BMD by age group. To test whether there was a
significant difference between the prevalence calculated
by the Korean reference and by the NHANES III refer-
ence, the McNemar–Bowker test and Cohen’s kappa
coefficient were used to evaluate the degree of diagnos-
tic agreement.
Results
Mean and standard deviation of bone mineral density by
age groups
The basic characteristics of the subjects are summarized
in Table 1. The mean BMD, height, and weight de-
creased as the subjects’ age increased. In Table 2, the
mean and standard deviation of BMD of each age group
was compared with the Korean BMD data and theNHANES III BMD data. The mean BMD of Korean
men, women, and women in the NHANES III decreased
with increasing age. There was a significant difference
between the mean BMD of the 20–29-year-old age
group and that of another age group in the KNHANES
2008–2011 (Table 3). However, in the NHANES III data,
there was no significant difference between those in their
20s and 30s. Table 3 and Figure 1 shows the decrease
in the mean BMD with increasing age by the reference
groups. The mean BMD was identified from highest to
lowest across all age groups as follows: Korean men >
NHANES III women > Korean women.
Agreement of diagnosis by each reference
If an agreement was found in the diagnosis of osteoporosis
based on each reference value, it was represented by the
sex and age group in Tables 4 and 5. For men, the results
of the diagnosis were calculated using the Korean refer-
ence and the NHANES III women reference, which were
fairly consistent. It was estimated by age groups as follows:
50s: k = 0.668, concordance 83.3%; 60s: k = 0.661, concord-
ance 81.1%; 70s: k = 0.654, concordance 81.4%; and 80s:
k = 0.633, concordance 78.1%. The concordance rate was
slightly decreased as age increased. Despite a high con-
cordance, there were statistically significant differences
between the diagnosis and each reference (McNemar-
Bowker test, p < 0.001). A significant difference was also
found in women; however, the degree of agreement was
Table 3 The mean bone mineral density (g/cm2) by age group
Age Male KNHANES 2008–2011 Female KNHANES 2008–2011 NHANES III
n Mean SD T* n Mean SD T* n Mean SD T*
20–29 976 0.9123 0.1336 a 1,236 0.7740 0.1045 a 409 0.8525 0.1189 a
30–39 1,569 0.8507 0.1195 b 2,098 0.7587 0.1030 b 518 0.8310 0.1210 a
40–49 1,591 0.8254 0.1160 c 2,071 0.7572 0.1043 b 444 0.7934 0.1273 b
50–59 1,449 0.7879 0.1118 d 1,996 0.6976 0.1011 c 450 0.7401 0.1196 c
60–69 1,412 0.7453 0.1125 e 1,778 0.6159 0.0881 d 454 0.6820 0.1206 d
70–79 962 0.6864 0.1103 f 1,283 0.5486 0.0876 e 556 0.6245 0.1088 e
80–89 183 0.6329 0.1176 g 306 0.3982 0.0809 f 420 0.5694 0.1057 f
SD, standard deviation; KNHANES, Korea National Health and Nutrition Examination Survey.
Welch test: p < 0.001.
*Post-hoc analysis (Tamhane’s T2); the letters represent the significant difference by age group.
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follows: 50s: k = 0.457, concordance 69.5%; 60s: k = 0.446,
concordance 71.1%; 70s: k = 0.553, concordance 75%; and
80s: k = 0.565, concordance 82%. While the difference in
the diagnosis was increased in aging men, the difference
in the diagnosis in women was decreased with an increas-
ing age. However, with regard to osteoporosis, the differ-
ence in the prevalence of osteoporosis was increased in
both sexes, except in women aged >80 years.
Figure 2 compares the prevalence of osteoporosis and
osteopenia according to the references. In men, when
the Korean reference value was used, the prevalence of
osteoporosis increased. In Figure 2 and Table 4, the dif-
ference in osteoporosis in men increased with age and
reached 9% for those in their 80s. In women (Figure 2
and Table 5), the prevalence of osteoporosis was higher
when the NHANES III white women reference was used.Figure 1 The mean and standard deviation of bone mineral
density (BMD) by age group from the Korea National Health and
Nutrition Examination Survey (KNHANES) 2008–2011 and
NHANES III. The mean BMD of KNHANES men, women, and NHANES
III white women were compared according to age group. The square,
triangle, and circle represent the mean BMD of the KNHANES males,
NHANES III white women, and KNHANES females, respectively.The differences in osteoporosis were 6%, 13%, 19%, and
17% for those in their 50s, 60s, 70s, and 80s, respectively.
The difference in the fracture risk probability compared
to the reference value
Figure 3 and Table 6 show the difference in the 10-year
major osteoporotic fracture probability. Figure 4 and
Table 7 show the difference in the 10-year femoral neck
fracture probability according to the T-score levels and
age groups. The results are summarized as follows.
Firstly, the differences in fracture risk were greater
in women than in men. For both major osteoporotic
fractures and femoral neck fractures, the difference of
probability in men was <2%. However, the difference
was higher in women. For major osteoporotic fractures,
the highest difference identified was 6% for those in their
50s with a T-score of −4.0 and one or two clinical risk
factors, and for those in their 70s with T-scores of −2.5
or −3.0 and two clinical risk factors. For femoral neck
fractures, the highest difference was 7% for those in their
50s with a T-score of −4.0 and one or two clinical risk
factors.
Secondly, the difference showed a tendency to increase
as the number of clinical risk factors increased. For
major osteoporotic fractures, this was most apparent in
men aged 80–89 years with a T-score of −2.5; the differ-
ence of 0.3% with no clinical risk factor increased up to
1.7% with two clinical risk factors. In women aged 80–
89 years, the difference of 1% with no clinical risk factor
increased up to 5% with two clinical risk factors. For
femoral neck fractures, the difference in men aged 80–
89 years with no clinical risk factor increased from 0.2%
to 2% with two clinical risk factors; for women in their
80s, the difference with no clinical risk factor increased
from 1.2% to 6% with two clinical risk factors.
Finally, in women with a T-score ≤ −3.5 and none or
one clinical risk factors, the difference in the major
osteoporotic fracture risk decreased with age. However,
in women with a T-score ≤ −3.0 and two clinical risk
Table 4 The change in diagnosis by the selected reference for males
Cohen’s k % of agreement Prevalence difference
50s k = 0.668 Agreement = 83.3% 1%
NHANES diagnosis
KNHANES diagnosis Normal Osteopenia Osteoporosis
n % n % n % n %
Normal 744 51.40 744 51.4 0 0 0 0
Osteopenia 685 47.30 230 15.9 455 31.4 0 0
Osteoporosis 19 1.30 0 0 11 0.8 8 0.5
Total 1,448 100.00 974 67.3 466 32.2 8 0.5
60s k = 0.661 Agreement = 81.1% 3%
NHANES diagnosis
KNHANES diagnosis Normal Osteopenia Osteoporosis
n % n % n % n %
Normal 514 36.40 514 36.4 0 0 0 0
Osteopenia 807 57.20 226 16.1 581 41.1 0 0
Osteoporosis 91 6.40 0 0 40 2.8 51 3.6
Total 1,412 100.00 740 52.5 621 43.9 51 3.6
70s k = 0.654 Agreement = 81.4% 6%
NHANES diagnosis
KNHANES diagnosis Normal Osteopenia Osteoporosis
n % n % n % n %
Normal 177 18.40 177 18.4 0 0 0 0
Osteopenia 634 66.00 123 12.8 511 53.2 0 0
Osteoporosis 150 15.60 0 0 56 5.8 94 9.8
Total 961 100.00 300 31.2 567 59 94 9.8
80s k = 0.633 Agreement = 78.1% 9%
NHANES diagnosis
KNHANES diagnosis Normal Osteopenia Osteoporosis
n % n % n % n %
Normal 20 10.90 20 10.9 0 0 0 0
Osteopenia 104 56.80 23 12.6 81 44.2 0 0
Osteoporosis 59 32.30 0 0 17 9.3 42 23
Total 183 100.00 43 23.5 98 53.5 42 23
McNemar-Bowker p-value for all comparisons < 0.001.
NHANES, National Health and Nutrition Examination Survey; KNHANES, Korea National Health and Nutrition Examination Survey.
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age. Table 6 shows data for women with a T-score −4.0
and one clinical risk factor, and the difference in the
probability was 6%, 5%, 4%, and 2% for those in their
50s, 60s, 70s, and 80s, respectively. But the difference in
women with T-score −2.5 and two risk factors increased
from 3% to 5% in 2 risk factors with aging. The tendency
was continued for femoral neck fracture in women with
T-score ≥ −3.0 and two clinical risk factors, but the
change in group with T ≤ −3.5 was slightly different little.
The decreased tendency with aging can be seen in
women with T-score between −2.5 to −4.0 and oneclinical risk factor. Table 7 shows data for the femoral
neck fractures in women with a T-score of −2 and two
clinical risk factors, and the difference of probability in-
creased from 1.5% for those in their 50s to 4% for those
in their 80s. But, the difference in women with T-score
−3.5 and one risk factor decreased from 4% to 1.3%.
Discussion
This study showed a significant difference between the
mean BMD of the NHANES III white women and of
Korean males and females, which used the 20–29-year-old
age group as a reference. The change in the reference
Table 5 The change in diagnosis by the selected reference for females
Cohen’s k % of agreement Prevalence difference
50s k = 0.457 Agreement = 69.5% 6%
NHANES diagnosis
KNHANES diagnosis Normal Osteopenia Osteoporosis
n % n % n % n %
Normal 741 53.10 390 28 351 25.1 0 0
Osteopenia 622 44.60 0 0 547 39.2 75 5.4
Osteoporosis 32 2.30 0 0 0 0 32 2.3
Total 1,395 100.00 390 28 898 64.3 107 7.7
60s k = 0.446 Agreement = 71.1% 13%
KNHANES diagnosis NHANES diagnosis
Total Normal Osteopenia Osteoporosis
n % n % n % n %
Normal 414 24.40 155 9.1 259 15.3 0 0
Osteopenia 1,100 64.80 0 0 870 51.2 230 13.6
Osteoporosis 183 10.80 0 0 0 0 183 10.8
Total 1,697 100.00 155 9.1 1,129 66.5 413 24.4
70s k = 0.553 Agreement = 75% 19%
KNHANES diagnosis NHANES diagnosis
Total Normal Osteopenia Osteoporosis
n % n % n % n %
Normal 101 7.90 27 2.1 74 5.8 0 0
Osteopenia 742 57.90 0 0 496 38.7 246 19.2
Osteoporosis 439 34.20 0 0 0 0 439 34.2
Total 1,282 100.00 27 2.1 570 44.5 685 53.4
80s k = 0.565 Agreement = 82% 17%
KNHANES diagnosis NHANES diagnosis
Total Normal Osteopenia Osteoporosis
n % n % n % n %
Normal 8 2.60 1 0.3 7 2.3 0 0
Osteopenia 99 32.40 0 0 51 16.7 48 15.7
Osteoporosis 199 65.00 0 0 0 0 199 65
Total 306 100.00 1 0.3 58 19 247 80.7
McNemar-Bowker p-value for all comparisons < 0.001.
NHANES, National Health and Nutrition Examination Survey; KNHANES, Korea National Health and Nutrition Examination Survey.
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porosis and on the fracture risk probability. The difference
in osteoporosis prevalence showed a rising tendency with
age; the difference increased to 9% in men aged 80–89
years and to 19% in women aged 70–79 years. We indir-
ectly investigated the difference in fracture risk probability
using the FRAX™ probability; the difference in risk
probability for major osteoporotic fractures from the
change in the reference was up to 2% in men and 6% in
women. In femoral neck fractures, the difference was up
to 2% in men and 7% in women. The degree of difference
was higher in women and in subjects with more clinicalrisk factors. For women with a T-score ≤ −3.5 and none or
one clinical risk factor, the difference decreased with age.
For women with a T-score ≥ −3.0 and two clinical risk fac-
tors, the difference increased with aging. This suggested
that the change in the gradient of risk (the degree of frac-
ture risk increased by 1 unit of decrease in the T-score)
may have been caused by the change in the reference value.
Fracture risk assessment tools represented by the FRAX™
are being introduced quickly; however, a T-score ≤ −2.5 is
still an important criterion for diagnosing and treating
osteoporosis. The importance of a reference value was di-
luted by using the FRAX™, because it used the BMD value
Figure 2 The prevalence of osteoporosis and osteopenia by age group (a, male; b, female). The differences in diagnoses from the reference
are represented by sex and age groups. The gray portion and lined dark gray portion indicate the prevalence of osteopenia and osteoporosis,
respectively. (a) In men, the prevalence obtained from the Korea National Health and Nutrition Examination Survey (KNHANES) male reference was
higher than the values obtained from the NHANES III women reference across all age groups. (b) In men, the prevalence obtained from the NHANES
III women reference was higher than the values obtained from the KNHANES female reference across all age groups.
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Figure 3 Differences in the 10-year risk probability for major osteoporotic fractures by age and the number of clinical risk factors
(CRFs). The differences in the 10-year fracture risk probability for major osteoporotic fractures from the reference are shown for men in the left
column and for women in the right column. Each row represents zero, one, or two CRFs in ascending order. The difference was higher in women
with more clinical risk factors than in men. KNHANES, Korea National Health and Nutrition Examination Survey.
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the T-score is still a criterion for diagnosing and treating
osteoporosis [10,25,26]. In addition, there was contro-
versy on the treatment duration of bisphosphonates, a
therapeutic agent for osteoporosis. Most studies on thisissue suggest the T-score as criteria for clinical decision
making [27]. Considering the use of the T-score in real
clinical situations, discussion relating to the selection of
the reference value directly related to the T-score is still
ongoing.
Table 6 Difference in the estimated fracture risk probability for major osteoporotic fractures
Male
T-score −1.5 −2 −2.5 −3 −3.5 −4
Korean Male 0.7119 0.6451 0.5783 0.5115 0.4447 0.3779
NHANES Female 0.6742 0.6147 0.5553 0.4958 0.4364 0.3769
Age No. of CRF Male, Difference in the fracture risk probability (%)
50s 0 0.4 0.4 0.8 0.6 1 0
1 0.8 0.9 2 1 2 0
2 1 1 2 1 2 0
60s 0 0.5 0.5 0.8 0.6 1 0
1 0.8 0.8 2 1 1 0
2 2 2 1 1 1 0
70s 0 0.5 0.4 0.6 0.4 1 0
1 0.7 0.7 0.9 0 1 0
2 1.1 1 2 1 1 0
80s 0 0.3 0.3 0.3 0.2 0.3 0
1 0.5 0.3 0.4 0.3 0.4 0
2 1.2 1 2 0 1 0
Female
T-score −1.5 −2 −2.5 −3 −3.5 −4
Korean Female 0.6173 0.5650 0.5128 0.4605 0.4083 0.3560
NHANES Female 0.6742 0.6147 0.5553 0.4958 0.4364 0.3769
Age No. of CRF Female, Difference in fracture risk probability (%)
50s 0 0.9 1 1.7 1.7 4 3
1 1.7 2 3 4 4 6
2 2 3 3 4 4 6
60s 0 1.2 1.4 1.8 2 2 3
1 2 2 4 3 4 5
2 3 3 4 4 4 5
70s 0 1.5 1.7 2.2 3 2 3
1 2.2 3 4 4 4 4
2 4 4 6 6 4 5
80s 0 1.1 1.4 2 1 1 2
1 1.1 2 2 3 2 2
2 4 4 5 5 3 4
KNHANES, Korea National Health and Nutrition Examination Survey; CRF, clinical risk factor.
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Osteoporosis Foundation, International Society for Clin-
ical Densitometry, WHO, and European guidelines rec-
ommend using the mean and SD of non-Hispanic white
women aged 20–29 from the U.S. NHANES III BMD
data as a reference and using the reference of women for
osteoporosis diagnoses in women [9-11]. This recom-
mendation was based on the fact that the difference of
BMD by region was small compared with the difference
in fracture incidence even if the BMD difference was sig-
nificant [3]. However, the definition of small should bebased on the effect of the reference on osteoporosis
diagnoses and the assessment of fracture risk.
The differences of prevalence identified in this paper
may have a significant effect on clinical decisions and
health policies. In previous studies on Koreans, the
prevalence of osteoporosis were reported as 0.3%, 2.6%,
7.9%, and 20.5% for men and as 5.3%, 16.8%, 43.4%, and
74.7% for women in their 50s, 60s, 70s, and 80s, respect-
ively, when the manufacturer’s reference was used [28].
Our study showed that the differences in osteoporosis
prevalence were 1%, 2%, 6%, and 9% for men and 6%,
Figure 4 Differences in the 10-year risk probability for femoral neck fractures by age and the number of clinical risk factors (CRFs). The
differences in the 10-year fracture risk probability for femoral fractures from the reference are shown for men in the left column and for women
in the right column in. Each row represents zero, one, and two CRFs in ascending order. The difference was higher in women with more CRFs
than in men.
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80s, respectively. These differences were considered sig-
nificant compared with the aforementioned osteoporosis
prevalence in Korea and can lead to under- or overesti-
mation of the proportion of osteoporosis. Therefore, itmay have an effect on the creation of health policies and
the criteria of reimbursement, etc. Thus, as for the effect
on clinical status, the differences from the change in the
reference should not be determined as small, numeric-
ally speaking.
Table 7 Difference in the estimated fracture risk
probability for femoral neck fractures
Male
T-score −1.5 −2 −2.5 −3 −3.5 −4
Korean Male 0.7119 0.6451 0.5783 0.5115 0.4447 0.3779
NHANES Female 0.6742 0.6147 0.5553 0.4958 0.4364 0.3769
Age No. of CRF Male, Difference in fracture risk probability (%)
50s 0 0.3 0.3 0.6 0.6 1.1 0
1 0.5 0.7 1.2 1.6 2 0
2 0.5 0.7 1.3 1.1 2 0
60s 0 0.3 0.3 0.6 0.6 0.8 0
1 0.5 0.6 1.1 0.9 1 0
2 0.5 1 1.1 1 1 0
70s 0 0.3 0.3 0.4 0.4 0.5 0
1 0.4 0.5 0.7 0.6 1.3 0
2 1 1 1.4 1 2 0
80s 0 0.2 0.1 0.2 0.2 0.2 0
1 0.3 0.3 0.3 0.2 0.3 0
2 1.1 1 2 1 0 0
Female
T-score −1.5 −2 −2.5 −3 −3.5 −4
Korean Female 0.6173 0.5650 0.5128 0.4605 0.4083 0.3560
NHANES Female 0.6742 0.6147 0.5553 0.4958 0.4364 0.3769
Age No. of CRF Female, Difference in fracture risk probability (%)
50s 0 0.5 0.7 1.4 1.8 3.8 3
1 1 1.5 2.8 3.2 4 7
2 1.1 1.5 2.9 3.8 5 7
60s 0 0.7 0.9 1.5 1.9 1.6 4
1 1.2 1.6 2.8 3.5 3 5
2 1.3 1.6 2.9 3.1 4 5
70s 0 0.9 1.1 1.8 2.1 2.1 3
1 1.3 1.7 1.7 2.7 3 4
2 2.7 3.6 5 5 5 6
80s 0 0.7 0.8 1.2 1.3 1.2 2
1 0.9 1.1 1.6 1.7 1.3 2
2 3.8 4 6 5 4 4
KNHANES, Korea National Health and Nutrition Examination Survey; CRF,
clinical risk factor.
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effect on the cut-off value for the BMD test and treat-
ment, which were the main elements in the guidelines
for osteoporosis. Kanis et al. reported that the sensitivity
and specificity of the fracture risk prediction changed
with the proportion of the fracture risk group [29]. In
this study, the proportion of saved fractures to the num-
ber screened also changed with the proportion of the
fracture risk group. The prevalence of osteoporosis is a
representative figure of the fracture risk group; thus, thechange in the prevalence can affect the criteria for deci-
sion making during the BMD test and treatment. There-
fore, the prevalence calculated by the Korean reference
can provide more acceptable criteria.
We can consider the change in the T-score level for
osteoporosis diagnosis (e.g., T-scores of −2.2 to −2.8 for
osteoporosis diagnosis) with maintaining the NHANES III
BMD data as the reference. By this methodology, the pro-
portion of osteoporosis in a specific region can be held
within a specific range [30]. Our study findings showed
that the NHANES III women reference was higher than
the KNHANES women reference; thus, the prevalence of
osteoporosis increased using the NHANES III women ref-
erence. If the diagnostic criterion for osteoporosis in-
creased to a T-score of −2.8, the prevalence may not
increase even if NHANES III reference was used. For ex-
ample, the osteoporosis prevalence diagnosed by the
Korean reference of women aged 70–79 years was 34%.
Assuming that this value was the real prevalence of osteo-
porosis in Korea, the prevalence can be consistent by
using the criterion of a T-score of −2.8, even if the
NHANES reference is used. However, by using this ap-
proach, the definition for diagnosing osteoporosis changes
from a T-score of ≤ −2.5 to a T-score of ≤ −2.8, which may
cause confusion among health care providers and health
policy makers, causing a significant increase in the cost of
time and money. In Korea, it took more than 5 years to
change the insurance standards for diagnosing osteopor-
osis with a T score of ≤ −3.0 to a T-score of ≤ −2.5.
A reason for using the NHANES III data was that
there were few well-structured BMD databases in many
areas [12,13]. The KNHANES 2008–2011 database was
equivalent to the NHANES III non-Hispanic white
women database in terms of sample size and study design.
The KNHANES 2008–2011 reference group was com-
posed of 976 males and 1,236 females aged 20–29 years
compared with 409 women of the NHANES III non-
Hispanic white women reference data. It was designed
well with an adequate sampling method and study design.
In addition, the Korean BMD reference data better
reflected the characteristics of the Korean BMD.
The change caused by selecting references can affect
the relationship between the T-score and the prediction
of fracture risk. In a 60-year-old woman with two clin-
ical risk factors (i.e., a previous fracture history and fam-
ily history for fracture), the difference in the 10-year risk
probability for femoral neck fractures, according to the
Korean version of the FRAX™, was 2.9% between the
Korean women reference and the NHANES III women
reference. The difference in a 70-year-old woman and an
80-year-old woman in the same conditions was 5% and
6%, respectively. This difference was decreased to 1.5%
for those in their 60s, 1.8% for those in their 70s, and
1.2% for those in their 80s. According to findings in
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ture was <5% for those in their 60s, 9% for those in their
70s, and 13% for those in their 80s [29]. When compar-
ing our study findings to those of previous findings, the
size in difference from each reference was significantly
large.
The difference in the BMD from the same T-score was
according to the range of subject’s T-score. In Tables 5
and 6, the difference in the BMD from the same T-score
decreased with a decreasing T-score. In men, the BMD
differences were 0.0377 g/cm2, 0.0304 g/cm2, 0.023 g/cm2,
0.0157 g/cm2, 0.0083 g/cm2, and 0.001 g/cm2 for T-scores
of −1.5, −2.0, −2.5, −3.0, −3.5, −4.0, respectively. The dif-
ference in women was greater than men. And, the BMD
differences also decreased with a decreasing T-score
(0.0569 g/cm2, 0.0497 g/cm2, 0.0425 g/cm2, 0.0353 g/cm2,
0.0281 g/cm2, and 0.0209 g/cm2 for T-scores of −1.5, −2.0,
−2.5, −3.0, −3.5, and −4.0, respectively). As a result, the
difference in the fracture risk probability was according
to sex and T-score. The difference in the BMD from
the same T-score was larger in women whose T-score
was > −3.5. This concluded that the reference change had
a significant effect on women with approximate T-score
of −2.5, for whom the diagnosis and decision making of
treatment was changed sensitively.
Our study has some limitations. First, it did not pro-
vide the degree of distribution of risk factors in the
groups. In the Korean version of the FRAX™, the risk
factors that had a significant effect on the fracture risk
probability were a history of fracture, family history of
fracture, and a history of steroid use. KNHANES 2008–
2011 did not have information on family history or a his-
tory of steroid use, but it included the data on a history
of previous fracture (n = 353, 8.6%). Second, instead of
the real fracture risk incidence, we used the estimated
fracture risk probability from the FRAX™. Ideally, the re-
lationship between the fracture incidence rate and the
change in reference was analyzed by regression analysis
with an adjustment for age, the number of clinical risk
factors, and the T-score. Because of these limitations,
we presented only a trend according to the associated
factors, and we were unable to provide statistical signifi-
cance for them as well as a better explanation for their
tendency.
Conclusions
The reference value has a significant effect on the preva-
lence of osteoporosis, and it affects the function of the
BMD for predicting the incidence of fractures. When
this significance is considered, the BMD data of the
KNHANES 2008–2011 reflected the characteristics of
the Korean population more precisely; therefore, it can
provide more realistic criteria for diagnosing and treat-
ing osteoporosis in Korea.Abbreviations
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